Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

TSE:8795 stock news

This page provides real-time market news, earnings updates, and company announcements related to T&D Holdings, Inc. (TSE:8795).

All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.

Last updated as of 2026-06-04 08:23 JST

PEDEVCO Reports Fourth Quarter and Full-Year 2025 Results image

PEDEVCO Reports Fourth Quarter and Full-Year 2025 Results

Finviz2026-03-31 21:51:10
Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update image

Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update

Finviz2026-04-01 21:03:44
Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response image

Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response

Finviz2026-04-02 11:03:13
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte's TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC) image

Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte's TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)

Finviz2026-04-02 11:06:06
Centene Announces New Executive Leadership Structure image

Centene Announces New Executive Leadership Structure

Finviz2026-04-06 11:03:55
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE image

AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE

Finviz2026-04-06 13:03:55
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center image

Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center

Finviz2026-04-07 11:06:54
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah image

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah

Finviz2026-04-09 13:03:43
Steel Dynamics Announces First Quarter 2026 Earnings Conference Call and Webcast image

Steel Dynamics Announces First Quarter 2026 Earnings Conference Call and Webcast

Finviz2026-04-09 14:03:49
Xanadu Announces Fourth Quarter and Full Year 2025 Results image

Xanadu Announces Fourth Quarter and Full Year 2025 Results

Finviz2026-04-09 21:09:02
Kornit Digital Redefines Apparel Production for the On-Demand Era Unveiling Atlas MATRIX at Konnections 2026 image

Kornit Digital Redefines Apparel Production for the On-Demand Era Unveiling Atlas MATRIX at Konnections 2026

Finviz2026-04-12 22:03:06
Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL image

Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL

Finviz2026-04-13 11:33:06
Palvella Therapeutics Appoints John D. Doux, M.D., M.B.A., Dermatologist and Recognized Leader in Rare Skin Diseases, to Board of Directors image

Palvella Therapeutics Appoints John D. Doux, M.D., M.B.A., Dermatologist and Recognized Leader in Rare Skin Diseases, to Board of Directors

Finviz2026-04-13 11:33:07
Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board image

Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board

Finviz2026-04-14 11:03:57
 Aletheia raises Nvidia price target to $270 ahead of earnings  image

Aletheia raises Nvidia price target to $270 ahead of earnings

Cryptobriefing2026-05-18 16:15:54
 Wall Street’s stock rally persists despite surge in US bond yields  image

Wall Street’s stock rally persists despite surge in US bond yields

Cryptobriefing2026-05-18 19:54:07
 Hedge funds boost semiconductor stocks to 19% of market exposure, the highest level ever recorded  image

Hedge funds boost semiconductor stocks to 19% of market exposure, the highest level ever recorded

Cryptobriefing2026-05-18 22:45:31
 Tuttle files for Magnificent 10 ETF, adding AMD, Broadcom, and Palantir to the mix  image

Tuttle files for Magnificent 10 ETF, adding AMD, Broadcom, and Palantir to the mix

Cryptobriefing2026-05-19 05:18:31
 Goldman Sachs outlines hedging strategies amid AI trade momentum  image

Goldman Sachs outlines hedging strategies amid AI trade momentum

Cryptobriefing2026-05-19 07:31:49
 Jim Cramer recommends Micron as a buying opportunity after selloff  image

Jim Cramer recommends Micron as a buying opportunity after selloff

Cryptobriefing2026-05-19 10:27:24

TSE:8795 stock price change

On the last trading day, TSE:8795 stock closed at 4250.00 JPY, with a price change of 1.14% for the day.

Trade stock perpsTSE:8795 stock details

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more
TSE:8795 stock news